Akadeum Life Sciences is a series b startup. 1 investor tracked.
Based in the United States, Akadeum Life Sciences is a startup founded in 2014. Its most recent tracked round is Series B. Brouky records 2 investors associated with the company.
Akadeum Life Sciences develops microbubble-based cell separation technology to improve the efficiency and cost-effectiveness of cell therapy manufacturing and research.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.